Skip to main content

Navigation group

Type at least 3 characters
314 articles

Articles

Original Research

Published on 16 Sep 2024

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

  • Atsushi Fukunaga
  • Yasumasa Kakei
  • Sae Murakami
  • Yuji Kan
  • Koji Masuda
  • Masatoshi Jinnin
  • Ken Washio
  • Hiroo Amano
  • Tohru Nagano
  • Akihisa Yamamoto
Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study
Frontiers in Immunology
doi 10.3389/fimmu.2024.1441478
  • 2,290 views